Efficacy and safety of duvakitug in patients with ulcerative colitis (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial

Study limitation reported by the research below: “Funding by Teva and Sanofi introduces potential industry bias; no independent replication data are available yet.”